A Prospective Randomized Study of the Use of an Oral Angiotensin II Receptor Blocker to Prevent Restenosis after Percutaneous Coronary Intervention

NAGASAWA Hidetaka; MUTOH Makoto; NOGIMURA Takeshi; SAKAMOTO Hiroshi; ONODA Satoru; NAKAE Sahachiro; TAMAKI Tetsuo; MATSUO Seiichiro; YOSHIDA Satoru; SHIBATA Takahiro; MOCHIZUKI Seibu

Art

J-GLOBAL ID：200902291305349727 Reference number：06A0255353

A Prospective Randomized Study of the Use of an Oral Angiotensin II Receptor Blocker to Prevent Restenosis after Percutaneous Coronary Intervention

経皮的冠動脈形成術後の再狭窄を予防するための経口アンギオテンシンII受容体きっ抗薬の使用の前向き無作為化試験

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=06A0255353&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0255353&from=J-GLOBAL&jstjournalNo=F0718A") }}

Author (11)： , , , , , , , , , ,
Material：
Volume： 52 Issue： 1 Page： 15-20 Publication year： Mar. 10, 2005
JST Material Number： F0718A ISSN： 0021-6968 CODEN： JMEJA Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0255353&from=J-GLOBAL&jstjournalNo=F0718A") }}

Clinical application of vasoactive drugs and hypotensive drugs , Drug therapy(=pharmacotherapy)for cardiovascular system diseases

Reference (23)：

PETERS, S. Valsartan for prevention of restenosis after stenting of type B2/C lesions : The VAL-PREST trial. J Invest Cardiol. 2001, 13, 9-97
NAFTILAN, AJ. Induction of planet-drived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989, 83, 1419-1424
TAMURA, K. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem. 1998, 273, 26487-26496
DAEMEN, MJ. Angiotensin II induces smooth muscle cell proliferation in the normal injured rat arterial wall. Circ Res. 1991, 68, 450-456
Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) study group. Does the new angiotensin coverting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study : a multicenter, randomized, double-blind, placebo-controlled trial. Circulation. 1992, 86, 100-110

ｍore...

, , , ,

Return to Previous Page